Anidulafungin-induced Hepatotoxicity and Dose Reduction: A Case Report
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2016, Vol 6, Issue 3
Abstract
Anidulafungin, the newest echinocandin antifungal recently approved by the U.S. FDA, is unique among echinocandins as it undergoes biotransformation rather than being metabolized. In general, patients who received anidulafungin demonstrated low rates of adverse events. Hepatotoxicity is uncommon with anidulafungin and to date; there is no information on hepatic dose adjustments and it is also unknown if the adverse events are dose-related. We describe a patient who developed raised alkaline phosphatase (ALP) upon exposure to a high maintenance dose of anidulafungin at 200 mg every morning. Our patient has a persistent active mitral valve Candida endocarditis, complicated with recurrent candidemia. Patient received multiple courses of anti-fungal agents but breakthrough while on oral anti-fungal suppressive therapy. Prior to the initiation of high dose anidulafungin therapy, patient’s liver function tests were all normal. One month after the initiation of high dose anidulafungin, repeat blood tests revealed a raised ALP level to 3 times the upper normal limit. As prolonged anti-fungal therapy is necessary, the maintenance dose of anidulafungin was reduced to 100 mg every morning, even though patient remained well. Three months after dose reduction, patient’s serum ALP levels showed a steady decrease to 1 time the upper normal limit. In this patient that we have reported – taking into consideration of the temporal relationship of events, coupled with the probability scoring using the Naranjo Algorithm, it is probable that anidulafungin may exhibit dose-related hepatotoxicity resulting in elevated serum ALP levels and such adverse events may be mitigated with dose reduction.
Authors and Affiliations
L. W. Loo, Jocelyn Teo, Tan Thuan Tong, Winnie Lee, Andrea L. Kwa
Endodontic Retrieval of Unusual Foreign Object from Root Canal of a Maxillary Central Incisor¬- A Case Report with 1 Year Follow-up and an Update
Aim: To enlighten and update the clinicians about the diagnosis and management of foreign body entrapment in root canal of a tooth. Case Presentation: The current case is of a single, uncommon case of a stapler pin in th...
Mauriac Syndrome in a 35 Year Old Woman With Type One Diabetes Mellitus
Mauriac syndrome is a rare complication of type 1 diabetes mellitus. It is characterized by hepatomegaly, growth delay and the presence of elevated transaminases and serum lipids. Mauriac syndrome occurs in males and fem...
Internal Resorption: A Report of Two Cases
Internal resorption is generally noted in teeth with previous history of trauma. Often the tooth is asymptomatic. The diagnosis of this condition at an early stage improves the prognosis of such teeth. Therefore it is im...
Spontaneous Closure of Patent Ductus Arteriosus in an Adult Patient: A Case Report
Patent Ductus Arteriosus (PDA) is a well-described congenital heart disease in infants and children but is less commonly reported in adults. Mechanical, surgical and spontaneous closure of PDAs in infants and fetuses are...
Intravenous Immunoglobulin in the Treatment of Patient with Acute Disseminated Encephalomyelitis: Case Report
Background: Acute disseminated encephalomyelitis (ADEM) is a monophasic process nevertheless sometimes aggravated by relapses (so-called multiphase course of the disease). The treatment of ADEM must be targeted at reduci...